Check out the companies making headlines before the bell:
Apple – Apple reported quarterly profit of $2.34 per share, beating the consensus estimate of $2.18 a share. Revenue also beat forecasts with a boost from Apple's iPhone X, and the company also gave upbeat revenue projections for the current quarter. Here's a wrap of all the major analyst opinions on Apple.
Pandora Media – Pandora lost 15 cents per share for its latest quarter, 1 cent a share less than Wall Street had anticipated. The streaming music service's revenue beat forecasts, and Pandora also said it now has about six million Pandora Premium subscribers.
Cheesecake Factory – Cheesecake Factory fell 16 cents a share short of forecasts, with adjusted quarterly profit of 65 cents per share. The restaurant chain's revenue was essentially in line with forecasts. Same-restaurant sales did increase during the quarter, but higher medical insurance and legal costs hurt the bottom line.
Top Medical Stocks To Own Right Now: Nationstar Mortgage Holdings Inc.(NSM)
Advisors' Opinion:- [By Joseph Griffin]
News coverage about Nationstar Mortgage (NYSE:NSM) has trended somewhat positive on Saturday, according to Accern Sentiment. The research firm identifies positive and negative news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Nationstar Mortgage earned a media sentiment score of 0.12 on Accern’s scale. Accern also gave media headlines about the financial services provider an impact score of 48.8354214982419 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
- [By Logan Wallace]
Eqis Capital Management Inc. purchased a new stake in Nationstar Mortgage Holdings Inc (NYSE:NSM) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 10,391 shares of the financial services provider’s stock, valued at approximately $182,000.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Nationstar Mortgage (NSM)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Schwab Charles Investment Management Inc. lifted its position in Nationstar Mortgage Holdings Inc (NYSE:NSM) by 4.1% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 149,406 shares of the financial services provider’s stock after buying an additional 5,824 shares during the quarter. Schwab Charles Investment Management Inc.’s holdings in Nationstar Mortgage were worth $2,684,000 as of its most recent filing with the SEC.
- [By Max Byerly]
LSV Asset Management raised its stake in shares of Nationstar Mortgage (NYSE:NSM) by 28.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 282,100 shares of the financial services provider’s stock after acquiring an additional 62,900 shares during the quarter. LSV Asset Management owned approximately 0.29% of Nationstar Mortgage worth $5,066,000 at the end of the most recent quarter.
Top Medical Stocks To Own Right Now: PRGX Global, Inc.(PRGX)
Advisors' Opinion:- [By Max Byerly]
PRGX Global (NASDAQ:PRGX) had its price objective boosted by B. Riley from $11.00 to $12.00 in a research note published on Wednesday. They currently have a buy rating on the business services provider’s stock. B. Riley also issued estimates for PRGX Global’s Q2 2018 earnings at ($0.07) EPS, Q3 2018 earnings at $0.08 EPS, Q4 2018 earnings at $0.27 EPS, FY2018 earnings at $0.18 EPS, Q1 2019 earnings at ($0.12) EPS, Q2 2019 earnings at ($0.05) EPS, Q3 2019 earnings at $0.17 EPS, Q4 2019 earnings at $0.32 EPS and FY2019 earnings at $0.33 EPS.
- [By Joseph Griffin]
PRGX Global (NASDAQ:PRGX) Director Matthew A. Drapkin purchased 35,766 shares of the company’s stock in a transaction that occurred on Thursday, May 31st. The stock was bought at an average cost of $9.64 per share, with a total value of $344,784.24. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
- [By Stephan Byrd]
PRGX Global Inc (NASDAQ:PRGX) – Stock analysts at Barrington Research cut their Q3 2018 earnings estimates for PRGX Global in a research note issued to investors on Wednesday, September 19th. Barrington Research analyst A. Paris. Jr now anticipates that the business services provider will post earnings of $0.04 per share for the quarter, down from their prior estimate of $0.07. Barrington Research has a “Buy” rating and a $13.00 price target on the stock. Barrington Research also issued estimates for PRGX Global’s FY2018 earnings at $0.09 EPS and FY2019 earnings at $0.28 EPS.
- [By Stephan Byrd]
These are some of the headlines that may have effected Accern’s analysis:
Get PRGX Global alerts: PRGX Global Inc (PRGX) Given $12.50 Average Target Price by Analysts (americanbankingnews.com) PRGX Global Inc (PRGX) Expected to Announce Quarterly Sales of $46.33 Million (americanbankingnews.com) Edited Transcript of PRGX earnings conference call or presentation 9-Aug-18 9:00pm GMT (finance.yahoo.com) Analysts Anticipate PRGX Global Inc (PRGX) Will Announce Earnings of $0.04 Per Share (americanbankingnews.com) Wednesday 8/22 Insider Buying Report: RIGL, PRGX (nasdaq.com)PRGX Global stock traded up $0.15 during mid-day trading on Friday, hitting $9.50. 100,780 shares of the company were exchanged, compared to its average volume of 51,706. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.57 and a quick ratio of 1.57. PRGX Global has a 1-year low of $6.45 and a 1-year high of $10.30. The firm has a market capitalization of $223.40 million, a P/E ratio of 45.24, a P/E/G ratio of 19.00 and a beta of 0.73.
- [By Max Byerly]
Get a free copy of the Zacks research report on PRGX Global (PRGX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top Medical Stocks To Own Right Now: LSI Industries Inc.(LYTS)
Advisors' Opinion:- [By Ethan Ryder]
LSI Industries, Inc. (NASDAQ:LYTS) Director John K. Morgan purchased 10,000 shares of the firm’s stock in a transaction on Wednesday, February 20th. The stock was bought at an average cost of $3.27 per share, with a total value of $32,700.00. Following the acquisition, the director now owns 35,880 shares of the company’s stock, valued at approximately $117,327.60. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
- [By Joseph Griffin]
LSI Industries, Inc. (NASDAQ:LYTS) CEO Ronald D. Brown acquired 5,000 shares of the business’s stock in a transaction on Monday, August 20th. The shares were bought at an average cost of $5.30 per share, with a total value of $26,500.00. Following the completion of the acquisition, the chief executive officer now owns 5,000 shares in the company, valued at $26,500. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.
No comments:
Post a Comment